Simpson Curran bought RGNX
June 30, 2026 · Form 4 insider transaction
Simpson Curran bought 1,453 shares of REGENXBIO Inc. at $10.18 per share, a transaction worth $14.8K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,453
Price
$10.18
Total value
$14.8K
InsiderSimpson Curran
RoleOfficer, Director
CompanyREGENXBIO Inc. (RGNX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 30, 2026
Filing dateJuly 6, 2026
Shares owned after344,871
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the ESPP for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is exempt under Rule 16b-3(c).; In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2026.